HopeStage
Back to all studies
CompletedNCT03395392

NRX-101 or Lurasidone for Depression in People With Bipolarity

About this title

NRX-101 for Bipolar Depression With Subacute Suicidal Ideation

Read the official source — NCT03395392

Researchers compared NRX-101 and Lurasidone HCl to find out how the approaches affected depression symptoms in adults with bipolarity during a depressive episode.

Medication studyAges 18–65United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared NRX-101 and Lurasidone HCl to find out how the approaches affected depression symptoms in adults with bipolarity during a depressive episode.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
Culver City and 13 more locationsSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: May 12, 2022
Recruitment status
Completed
Enrollment listed in the registry
74
Sponsor
NeuroRx, Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT03395392
Official title
Show the full official title

A Randomized, Double-Blind Controlled Comparison of NRX-101 to Lurasidone for Adults With Bipolar Depression and Subacute Suicidal Ideation or Behavior

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Culver City · Miami Lakes · Atlanta

10 more locations
  • Decatur
  • Savannah
  • Gaithersburg
  • Omaha
  • Amherst
  • Eugene
  • Austin
  • Fort Worth
  • Houston
  • Richmond

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared NRX-101 and Lurasidone HCl to find out how the approaches affected depression symptoms in adults with bipolarity during a depressive episode.

Who is behind this study?

The study sponsor is NeuroRx, Inc.

Did this study involve medication?

Yes. The study involved medication, including NRX-101 and Lurasidone HCl.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies